Discovery of potent and selective novel small molecule drugs to target estrogen receptor mutants in endocrine-resistant breast cancer

被引：0
|
作者：
Devakrishnan, Anil Kumar
Madasu, Chandrashekhar
Fuqua, Suzanne A. W.
Matzuk, Martin M.
Palaniappan, Murugesan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6576
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
    Yubo Wang
    Jian Min
    Xiangping Deng
    Tian Feng
    Hebing Hu
    Xinyi Guo
    Yan Cheng
    Baohua Xie
    Yu Yang
    Chun-Chi Chen
    Rey-Ting Guo
    Chune Dong
    Hai-Bing Zhou
    Acta Pharmaceutica Sinica B, 2023, (12) : 4963 - 4982
  • [2] Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
    Wang, Yubo
    Min, Jian
    Deng, Xiangping
    Feng, Tian
    Hu, Hebing
    Guo, Xinyi
    Cheng, Yan
    Xie, Baohua
    Yang, Yu
    Chen, Chun-Chi
    Guo, Rey-Ting
    Dong, Chune
    Zhou, Hai-Bing
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (12) : 4963 - 4982
  • [3] Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo
    Xie, Baohua
    Yin, Zhinang
    Hu, Zhiye
    Lv, Junhui
    Du, Chuanqian
    Deng, Xiangping
    Huang, Yuan
    Li, Qiuzi
    Huang, Jian
    Liang, Kaiwei
    Zhou, Hai-Bing
    Dong, Chune
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (10) : 6631 - 6651
  • [4] Discovery of Thiochroman Derivatives as Potent, Oral Selective Estrogen Receptor Degraders and Antagonists for the Treatment of Endocrine-Resistant Breast Cancer
    Zhang, Dan
    Lu, Zhengyu
    He, Yongqi
    Leng, Xin-Yu
    Meng, Xin
    Lei, Xiang
    Kong, Deyu
    Sun, Lulu
    Hu, Wenhao
    Yang, Yushe
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21545 - 21567
  • [5] Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer
    Lu, Yunlong
    Liu, Wukun
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15094 - 15114
  • [6] Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer
    Deng, Xiangping
    Deng, Xiaofei
    Ning, Wentao
    Xin, Lilan
    Li, Qiuzi
    Hu, Zhiye
    Xie, Baohua
    Liang, Kaiwei
    Min, Chang
    Dong, Chune
    Huang, Jian
    Zhou, Hai-Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 11094 - 11117
  • [7] Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches
    Shete, Nivida
    Calabrese, Jordan
    Tonetti, Debra A.
    CANCERS, 2023, 15 (14)
  • [8] Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation
    Guest, Stephanie K.
    Ribas, Ricardo
    Pancholi, Sunil
    Nikitorowicz-Buniak, Joanna
    Simigdala, Nikiana
    Dowsett, Mitch
    Johnston, Stephen R.
    Martin, Lesley-Ann
    PLOS ONE, 2016, 11 (06):
  • [9] Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer
    Nicholson, RI
    Hutcheson, IR
    Harper, ME
    Knowlden, JM
    Barrow, D
    McClelland, RA
    Jones, HE
    Wakeling, AE
    Gee, JMW
    HORMONE-RELATED TUMORS: NOVEL APPROACHES TO PREVENTION AND TREATMENT, 2002, 963 : 104 - 115
  • [10] Discovery of GDC-0810 a novel, non-steroidal selective estrogen receptor degrader with robust activity in pre-clinical models of endocrine-resistant breast cancer
    Joseph, James
    Govek, Steven
    Darimont, Beatrice
    Brigham, Daniel
    Aparicio, Anna
    Bischoff, Eric
    Kahraman, Mehmet
    Nannini, Michelle
    Kaufman, Joshua
    Lai, Andily
    Lee, Kyoung-Jin
    Oeh, Jason
    Lu, Nhin
    Zhou, Wei
    Moon, Michael
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Sampath, Deepak
    Friedman, Lori S.
    Rix, Peter
    Heyman, Richard A.
    Smith, Nicholas
    Hager, Jeffrey H.
    CANCER RESEARCH, 2015, 75
12345